Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker
for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging …

Globally, hepatocellular carcinoma (HCC) is the fourth most common cause of death from
cancer. The prevalence of this pathology, which has been on the rise in the last 30 years …

Objective. To investigate the diagnostic value of magnetic resonance imaging (MRI)
combined with serum alpha‐fetoprotein (AFP), alpha‐fetoprotein (AFP‐L3), Golgi protein 73 …

Hepatocellular carcinoma (HCC) is one of the most common and highly lethal tumors
worldwide. Microvascular invasion (MVI) is a significant risk factor for recurrence and poor …

Liver cancer ranks as the sixth most common cancer globally, with hepatocellular carcinoma
(HCC) accounting for approximately 75%–85% of cases. Most patients present with …

Hepatocellular carcinoma (HCC) is a longstanding issue in clinical practice and metabolic
research. New clues in better understanding the pathogenesis of HCC might relate to the …

The incidence of Hepatocellular carcinoma (HCC) is rising at an alarming rate. It is now the
third leading cause of cancer deaths worldwide. Non-alcoholic fatty liver disease (NAFLD) …

Background There is an urgent need to identify novel biomarkers for hepatocellular-
carcinoma (HCC) patients who cannot be diagnosed early as in very small lesions and …

Background: Caregivers of patient with hepatocellular carcinoma have great burden in
caring their patients and having crucial role for management of their diseases. Aim: the …